Literature DB >> 8092107

Hypersensitivity reactions to etoposide. A report of three cases and review of the literature.

P de Souza1, M Friedlander, C Wilde, F Kirsten, M Ryan.   

Abstract

Etoposide (VP 16) is an antineoplastic agent that has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. It is a derivative of podophyllin, and acts by inhibiting mitosis. Common side effects include bone marrow suppression, alopecia, and gastrointestinal symptoms. Hypersensitivity reactions are uncommon however, and the underlying mechanism is unclear. We report three cases of etoposide hypersensitivity and review the literature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092107

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  2 in total

1.  Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.

Authors:  J Siderov; P Prasad; R De Boer; J Desai
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

2.  Risks and mitigation strategies to prevent etoposide infusion-related reactions in children.

Authors:  Emma M Tillman; Sarah L Suppes; Nicholas Miles; Ashley M Duty; Kelsey L Kelley; Jennifer L Goldman
Journal:  Pharmacotherapy       Date:  2021-06-29       Impact factor: 4.705

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.